Although it remains unclear whether β cell clock disruption is a cause or consequence of T2D, treating such islets with nobiletin, a RORα agonist, has positive effects on both clock gene expression and insulin release [83,108,109]. The gene discussed is INS; the disease is type 2 diabetes mellitus.